Prostate cancer: open trials in Argentina

12 open trials have a site in Argentina. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Instituto Alexander Fleming-Alexander Fleming ( Site 0206), Buenos Aires · Hospital Aleman-Oncology ( Site 0207), Buenos Aires · Asociación de Beneficencia Hospital Sirio Libanés ( Site 0205), Buenos Aires · Hospital Británico de Buenos Aires-Oncology ( Site 0202), Ciudad Autónoma de Buenos Aires · Instituto de Investigaciones Clínicas Mar del Plata ( Site 0201), Mar del Plata · Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 0204), Mendoza · Sanatorio Parque ( Site 0208), Rosario
Registry updated 2026-11-05
NCT06629779
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Trial Treatment · Phase 3 · Pfizer
IMAXE, Buenos Aires · Centro Medico Fleischer, Buenos Aires · Centro de Urología (CDU), CABA · Centro Medico Privado CEMAIC, Capital · Hospital Sirio Libanes, Capital Federal · Hospital Privado Centro Medico de Cordoba, Córdoba · Instituto de Investigaciones Clinicas Mar del Plata, Mar del Plata · Imagenes Mdq, Mar del Plata
Registry updated 2026-10-30
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 0136), Berazategui · Centro Medico Dra De Salvo ( Site 0132), CABA · Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0131), La Rioja · Instituto Alexander Fleming ( Site 0125), Mar del Plata · Instituto de Investigaciones Clinicas Mar del Plata ( Site 0129), Mar del Plata · Centro Oncologico de Integracion Regional. COIR ( Site 0130), Mendoza · Sanatorio Parque ( Site 0126), Rosario · Centro de Diagnostico Investigación y Tratamiento Oncológico (CeDIT) ( Site 0135), Salta · Instituto San Marcos ( Site 0137), San Juan
Registry updated 2026-10-30
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Trial Treatment · Phase 1/2 · Pfizer
Fundacion Respirar, Buenos Aires · Fundacion CENIT para la Investigacion en Neurociencias, Caba · Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires · Clínica Universitaria Reina Fabiola, Córdoba · Fundación CORI para la Investigación y Prevención del Cáncer, La Rioja
Registry updated 2026-10-28
NCT07892378
Multiparametric Magnetic Resonance Imaging (mpMRI) Versus Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) for Detecting Clinically Significant Prostate Cancer in Transition Zone Lesions /PRostate Imaging With MRI and PET in the Transition Zone (PRIME-TZ)
Research · Sanatorio Privado San Geronimo
Sanatorio San Geronimo, Santa Fe
Registry updated 2026-10-23
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
CABA
Registry updated 2026-10-21
NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Trial Treatment · Phase 3 · AstraZeneca
CABA · Ciudad de Buenos Aires · Córdoba · Cuidad Autónoma de Buenos Aire · La Plata · Pergamino · Rosario · San Miguel de Tucumán · Viedma
Registry updated 2026-10-14
NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Trial Treatment · Phase 3 · Pfizer
Centro Oncologico Korben, Buenos Aires · Asociación de Beneficencia Hospital Sirio Libanés, Ciudad Autonoma de Buenos Aires · Investigaciones Oncológicas C. Colón S.A, Mar del Plata · Centro de Investigación Pergamino, Pergamino · Sanatorio Británico, Rosario · Instituto de Oncología de Rosario, Rosario
Registry updated 2026-10-14
NCT06863272
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Instituto Alexander Fleming ( Site 0202), Ciudad Autónoma de Buenos Aires · Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0200), La Rioja
Registry updated 2026-10-09
NCT07753356
VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY
Research · Marcelo Ruben Oliva
Clinica Cemep, Rio Grande
Registry updated 2026-08-07
NCT06717295
The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
Research · Javier Toledo
Various Cancer Centres, Rosario
Registry updated 2026-01-02
NCT07299292
Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)
Trial Treatment · Phase 2 · SMED Clinical Research
Hospital Carlos A Durand, Buenos Aires
Registry updated 2025-12-23

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error